Dr Leeza Osipenko is a Senior Lecturer in Practice. She joined the LSE Department of Health Policy in September 2018.
Between 2014 and 2018 she led Scientific Advice at the National Institute for Health and Care Excellent (NICE). She chaired over 150 advisory meetings at NICE and at the EMA (European Medicines Agency) and closely collaborated with EUnetHTA and MHRA. At NICE, Dr Osipenko provided methodological, operational, and strategic leadership for the team which became well-known internationally. During those years Dr Osipenko represented NICE as a Chief Analyst at the Department of Health Appraisal Alignment Working Group.
Prior to joining NICE, she did a post-doc at Warwick Medical school and worked as Principal Economist at the public sector consultancy, Optimity Matrix.
Health technology assessment methodologies
Health policy, pharmaceuticals, evidence based medicine
PhD Systems Engineering, Stevens Institute of Technology, USA
HP424 Pharmaceutical Economics and Policy
HP4C3E Economic Evaluation in Health Care
HP4C4E Systematic Review and Meta-analysis
Visiting Fellow, Center for Global Development